Alto Pharmacy, a San Francisco-based digital pharmaceutical startup, raised $40 million through a convertible note. SoftBank Group Corp. is participating in the deal. Despite a recent valuation decline to $786 million, Alto continues to attract investor interest.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing